Last Posted: Mar 23, 2017
Breast cancer and genomic testing.
Liedtke C et al. The British journal of surgery 2017 Mar
Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect.
Guindalini Rodrigo Santa Cruz et al. Cancer 2016 122(12) 1913-20
Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?
McGee Jacob et al. Gynecologic oncology 2017 Mar
The effect of a celebrity health disclosure on demand for health care: trends in BRCA testing and subsequent health services use.
Roberts Megan C et al. Journal of community genetics 2017 Mar
Evolving Trends and Influencing Factors in Mastectomy Decisions.
Bhat Sneha et al. The American surgeon 2017 Mar 83(3) 233-238
Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2Positive Breast Cancer
Analysis of the NSABP B-31 Trial
PG Gavin et al, JAMA Oncology, March 2017
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.